A day-long event in Calgary with a who’s who from the rare disease and Duchenne communities, including Brett Billmeyer (PTC Therapeutics), Ryan Clarke and Joanne Koskie (advocacy solutions), Dr. Michael Rudnicky (Ottawa Hospital), Dr. Laura Hagert (ReveraGen BioPharma), Dr. Lawrence Korngut (Canadian Neuromuscular Disease Registry), Dr. Jean Mah (Alberta Children’s Hospital), and Lauren Morgenroth (TRiNDS).
The event is hosted by Jesse’s Journey, a registered charitable organization that has funded more than $11.5 million in research projects around the world, and is the ONLY Canadian charity that exists solely to fund Duchenne muscular dystrophy research.
For more information about the event, visit www.jessesjourney.com/defeat-duchenne-family-forum-calgary/
Topics will include: Research updates on CAR-T and clinical trial innovations, powerful survivor stories, and treatment breakout sessions for AML, ALL, CLL, and CML.
This one day conference, held at the VanDusen Botanical Gardens in Vancouver BC, will allow patients and caregivers an opportunity to learn more about the latest research in leukemia.
For more information, click here.
Putting Patients First is an annual conference designed to encourage learning and collaboration between patients interested in patient-oriented research (POR), health researchers, health care providers and health system decision makers.
Guest speakers include Dr Evan Adams (Chief Medical Officer, First Nations Health Authority) and Jennifer Johannesen (author of No Ordinary Boy).
BC Cancer’s interdisciplinary summit is November 21 to November 23, 2019 at the Sheraton Wall Centre in Vancouver. This three-day event provides critical education, professional development and unique relationship-building opportunities for oncology professionals from all specialties and disciplines.
For more information, visit bccancersummit.ca